Market News & Trends
Catalent Biologics Expands Into ADCs Through Exclusive License
Catalent Pharma Solutions recently announced it has acquired an exclusive license to market Redwood Bioscience's proprietary SMARTag precision protein-chemical engineering technology for the development of…
Cyclica & Dalton Announce Drug Development Collaboration
Cyclica and Dalton recently announced a collaboration agreement to identify and develop new drug candidates applying advanced computational molecular design to medicinal chemistry and drug…
GSK & A*STAR to Develop New Medicines for Emerging Markets
GlaxoSmithKline (GSK) and A*STAR's Institute of Chemical and Engineering Sciences (ICES) have signed a 5-year strategic agreement to develop new evidence-based formulations (EBFs) specifically for…
Lipid Therapeutics Successfully Files US IND
Lipid Therapeutics recently announced it has successfully filed its first US IND for its lead product LT-02 and is now in a position to proceed…
Aragen Bioscience & Innovent Biologics Announce Collaboration for Biotherapeutic Product Development
Aragen Bioscience, Inc. and Innovent Biologics, Inc. have initiated a collaboration for the development of manufacturing cell lines for biotherapeutic product development. Under the terms…
Foster Expands Nano-Reinforced Polymer Product Range for Medical Devices
Foster Corporation now offers nano-reinforced composites for minimally invasive devices, such as catheters, with reinforcement loadings up to 30% by weight. Nano-reinforced compounds with high…
Hovione Announces a Co-Promotion & Collaboration Agreement
Hovione recently announced a co-promotion and collaboration agreement with Ligand to provide Hovione's customers efficient access to Captisol technology. Captisol, a chemically modified cyclodextrin, is…
Unilife Signs Long-Term Customization & Commercial Supply Agreement; $110-Million Potential
Unilife Corporation recently announced the signing of a Customization and Commercial Supply Agreement with a US pharmaceutical company for the EZMixTM dual-chamber syringe. Unilife will…
US Nanotechnology Drug Delivery Market Forecast to Grow Significantly Through 2016
Research activities in healthcare have changed significantly in recent years. There has been a paradigm shift away from blockbusters drugs to a more personalized medicine…
Vetter's New Commercial Filling Line Ready for cGMP Filling
Vetter recently announced that its new award-winning filling line at the company's Ravensburg Vetter South facility is fully validated and ready for cGMP filling, after…
VIVUS Announces $110-Million Synthetic Capped Royalty Financing
VIVUS, Inc. recently announced that it has entered into a $110-million non-equity financing with an investment fund managed by Pharmakon Advisors. Under the terms of…
Aastrom Biosciences Announces Strategic Change in R&D Programs
Aastrom Biosciences, Inc. recently announced a strategic change in its research and development programs to focus on the clinical development of its lead product, ixmyelocel-T,…
Biodel Completes Phase II Enrollment in Clinical Trial of Ultra-Rapid-Acting Insulin
Biodel Inc. recently announced the completion of patient enrollment in a Phase II clinical study of ultra-rapid-acting prandial insulin candidate BIOD-123 for the treatment of…
Foster Delivery Science Receives Grant to Develop Process for Oral Dose Drug Delivery
Foster Delivery Science recently announced it has been awarded a Manufacturer's Technical Assistance Program (MTAP) grant from the University of Connecticut for development of novel…
Medicyte Signs Development Agreement With Life Technologies
Medicyte recently announced it has signed a licensing agreement for the rights to use Lentiviral vector technology from Life Technologies to develop and market next-generation,…
RedHill Biopharma Submits NDA for Oral Thin Film Drug
RedHill Biopharma Ltd. recently announced the company and its co-development partner, IntelGenx Corp., have submitted a New Drug Application (NDA) to the USFDA seeking marketing…
Biogen's Injectable Drug Significantly Cuts Relapse Rate
Biogen Idec recently announced the positive, full first-year results from its 2-year pivotal Phase III ADVANCE study of PLEGRIDY (peginterferon beta-1a), the company's investigational candidate…
Cerecor Acquires Rights to COMT Inhibitors
Cerecor Inc. recently announced it has acquired exclusive, worldwide rights to develop, register, and commercialize agents that inhibit catechol-O-methyltransferase inhibitors (COMT inhibitors), previously discovered and…
Cook Pharmica Receives Additional Approval From US FDA
Cook Pharmica, which develops and manufactures pharmaceutical and biopharmaceutical products on a contract basis, recently received more good news from the US FDA. The company…
Enanta Pharmaceuticals Raises $56-Million in IPO
Enanta Pharmaceuticals, Inc. recently announced the pricing of its initial public offering of 4,000,000 shares of its common stock at a price to the public…
